Fungus
Candidiasis
search
Candidiasis
, Moniliasis, Urinary Tract Candidiasis, Candiduria
See Also
Cutaneous Candidiasis
Candida Diaper Dermatitis
Candida Vulvovaginitis
Thrush
Etiology
Candida albicans
Risk Factors
Skin maceration
Immunosuppressed patients
Advanced
Human Immunodeficiency Virus
(
AIDS
)
Hematologic Malignancy
Antibiotic use
Corticosteroid
use
Pregnancy
Diabetes Mellitus
Signs
Systemic involvement in
Immunocompromised
patient
Severe
Muscle
tenderness
Signs
Mucocutaneous Rash
Character
Erythematous
Papule
s
Pruritic, eroded areas
Scaling
and crusting of lesions
Normal Distribution (Not
Immunocompromised
)
Mouth
Vagina
Axillae
Inguinal folds
Interdigital surfaces
Signs
Specific Lesions
Oral
Thrush
White
Plaque
s firmly adhered to
Oral Mucosa
Cutaneous Candidiasis
Red, macerated intertriginous areas
Chronic mucocutaneous Candidiasis
Circumscribed hyperkeratotic skin lesions
Dystrophic Nail
s
Partial
Alopecia
Oral and vaginal
Thrush
Endocrine organ hypofunction
Hypoparathyroidism
Hypothyroidism
Adrenal Insufficiency
Gastrointestinal
Distal
Esophagus
ulcerations
Hematogenous (Immunosuppressed)
Fever
Malaise
Retina
l abscess
Pulmonary nodular infiltrate
Endocarditis
Labs
Abscess drainage shows candida mycelia
Candida
Serology
titers elevated
KOH Preparation
Pseudohyphae
Management
Gene
ral
Cutaneous
Nystatin
Ciclopirox
Imidazole cream
Oral
Thrush
Clotrimazole
One troche dissolve in mouth x5 qd for 7-14 days
Nystatin
suspension
Swish and swallow 4-6 times per day for 7-14 days
Fluconazole
100 mg PO qd for 7-14 days
Esophageal
Fluconazole
100-200 mg PO/IV qd for 14-21 days
Amphotericin B 0.3 mg/kg/day for 5-10d
Indicated for severe cases only
Ketoconazole
200-400 mg orally daily for 14-21 days
Indicated only for severe, refractory cases due to
Ketoconazole
hepatotoxicity
If
Ketoconazole
is used, requires
Liver Function Test
s at baseline and again weekly
Management
Urinary Tract Candidiasis (Candiduria)
Asymptomatic Candiduria (on
Urinalysis
) does not require treatment unless otherwise indicated
Pre-Urologic procedure and Candiduria
Fluconazole
(
Diflucan
) 3-6 mg/kg to 200-400 mg orally or IV once daily for 2-3 days before and after procedure OR
Amphotericin B 0.3 to 0.6 mg/kg once daily for 2-3 days before and after procedure
Symptomatic Candiduria (or asymptomatic with risks)
Indications for treatment in asymptomatic patients
Neutropenia
Low Birth Weight Infant
Pregnancy
First-line agents
Fluconazole
(
Diflucan
) 3 mg/kg up to 200 mg orally or IV once daily for 14 days
Increase dose to 6 mg/kg up to 400 mg orally daily for
Pyelonephritis
Alternative Agents (e.g.
Fluconazole
resistance)
Amphotericin B 0.5 mg/kg once daily for 7 days (14 days for
Pyelonephritis
) OR
If
Urinary Catheter
, may irrigate with Amphotericin B 50 mg in 1L x5-7 days
Flucytosine 25 mg/kg four times daily for 14 days
References
Fisher (2011) Clin Infect Dis 52 (Suppl 6):S457-66 +PMID:21498839 [PubMed]
https://academic.oup.com/cid/article/52/suppl_6/S457/285164
Management
Disseminated
Empiric broad Candidiasis coverage or known resistant Candidiasis (Candida glabrata or Candida krusei)
Caspofungin 70 mg IV load, then 50 mg IV every 24 hours or
Micafungin 100 mg IV every 24 hours or
Anidulafungin 200 mg IV load, then 100 mg IV every 24 hours
Known Candida albicans or Candida parapsilosis or Candida tropicalis
Fluconazole
800 mg (12 mg/kg) load then 400 mg IV or oral daily
Alternative empiric protocols
Amphotericin B 0.7 mg/kg IV daily (or lipid based Amphotericin B 3-5 mg/kg daily) or
Fluconazole
800 mg (or 12 mg/kg) load then 400 mg IV or oral daily or
Voriconazole 400 mg (or 6 mg/kg) IV twice daily for 2 doses, followed by 200 mg every 12 hours
References
Gilbert (2013) Sanford Antibiotic Guide
Type your search phrase here